BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
HIV infection
,
Kidney
,
Laser capture microdissection
,
Ciprofibrate
,
rs3825942
,
FOXP1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
5' exoribonuclease
Summary
General Info
Curated Studies
Most Correlated Studies
Stromal cell gene expression in response to treatment with tumor cell-derived exosomes
Kidney embryonic 273 cells overexpressing exoribonuclease DIS3L2 D391N mutant
Embryonic kidney HEK293 cells overexpressing mutant or wildtype DIS3L2
Acute monocytic leukemia THP1 cells depleted of GLD2 or PAPD5
Colorectal cancer HCT 116 cells with XRN1 shRNA knockdown
Explore Curated Studies Results
Literature
Most Relevant Literature
The role of the 5'-3' exoribonuclease XRNA in transcriptome-wide mRNA degradation.
Activation of 5'-3' exoribonuclease Xrn1 by cofactor Dcs1 is essential for mitochondrial function in…
A mammalian pre-mRNA 5' end capping quality control mechanism and an unexpected link of capping to p…
Messenger RNA degradation is initiated at the 5' end and follows sequence- and condition-dependent m…
Dxo1 is a new type of eukaryotic enzyme with both decapping and 5'-3' exoribonuclease activity.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Remdesivir in COVID-19 Lahore General Hospital
"Efesovir" (FS-1) for COVID-19, Phase 2
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ